By Karen Deyo, Director of Investor Research, Israel BD, LSN

As many around the world prepare for a litany of winter holidays celebrated globally, the early-stage life science and healthcare world enthusiastically awaits the start of their own winter festival: JPM Week. Whether virtual, in-person, or hybrid, events associated with JPM Week are expected to fill up with buyers and sellers seeking connections and to make deals.

At Digital RESI JPM, attendees can expect an agenda packed with investor panel discussions, insightful tales from the road from successful entrepreneurs, pitch sessions, educational workshops, and more – all designed to help the early-stage entrepreneur understand their audience and make the connections that best match their product and stage of development. Check out the Digital RESI JPM agenda below and sign up by December 17 to save $200!

	Tuesday (1/11)	Wednesday (1/12)	Thursday (1/13)
10AM EST	Innovator’s Pitch Challenge #1	Family Offices Panel	Innovator’s Pitch Challenge #8
		Innovator’s Pitch Challenge #5
11AM EST	Medical Devices Investor Panel	Defining and Funding Age-Tech Innovations Panel	Diagnostics Investor Panel
12PM EST	Workshop (TBD)	Workshop (TBD)	Workshop (TBD)
1PM EST	Innovator’s Pitch Challenge #2	Innovator’s Pitch Challenge #6	Innovator’s Pitch Challenge #9
2PM EST	The Regulatory Pathway for AI in Healthcare Panel	Digital Health Investor Panel	Emerging Products and Technologies for Aging at Home Panel
3PM EST	Big Pharma Panel	The Early Stage Pivot Panel	Corporate VC Panel
	Innovator’s Pitch Challenge #3		Innovator’s Pitch Challenge #10
4PM EST	Tales from the Road: Age-Tech Innovators on their Fundraising Journey	Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey	Tales from the Road: AI Innovators on their Fundraising Journey
5PM EST	Longevity Investors Share Their Investment Thesis	Longevity Entrepreneurs Discuss Their New Products	Innovator’s Pitch Challenge #11
	Innovator’s Pitch Challenge #4	Innovator’s Pitch Challenge #7

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Last month, Life Science Nation wrapped up its final Innovator’s Pitch Challenge (IPC) of the year. While the team is busy preparing for our next one at JPM Week, January 11-13, we would be remiss not to announce and celebrate the winners of the Digital RESI November IPC!

1st Place Sana Health	2nd Place Braingrade	3rd Place MOWOOT

Learn more about our winners and how they are shaping the early-stage ecosystem with their technology. Winners are chosen by the votes of our attendees who can access their dedicated landing pages and pitch materials, as well as participate in the live Q&A session. If you’re interested in joining the next IPC, applications are open until December 17. Applications are accepted on a rolling basis, so send yours in today!

FDA Breakthrough device designation for fibromyalgia (class II), Sana is an audiovisual neuormodulation device that gives anxiety relief on demand, giving it applications across pain, mental health and long covid. We have recently completed a pivotal study in Fibromyalgia with Duke, which will be submitted to the FDA as a Denovo in the next month. We also have a pivotal study underway in Neuropathic pain at Mount Sinai, and two more pivotals in Anxiety and PTSD due to start in Q1. We recently were awarded a DoD grant for PTSD. We are on market under a 513g Designation as a wellness device, allowing for speedy clinical trials and adoption. Future areas – depression, lower back pain and long covid. The user puts on the device, and pulses of light and sound induce deep relaxation or sleep within 16 minutes.

Braingrade is developing a brain co-processor, the next-generation brain-machine interface to enhance human cognition. As it?s first indication, the company is targeting Alzheimer?s Disease (AD). The Braingrade memory implant is a fully implantable (invisible, under the skin) deep brain stimulator. The device is capable of detecting abnormal neural activity across multiple brain regions and applying AI-optimized, patterned, electrical stimulation to rectify affected memory circuit oscillations and restore healthy brain activity. It does this through novel probes that use a new material allowing more electrodes at a smaller scale. Braingrade is comprised of a team of experts in all facets of neuro-engineering, with a proven track record of collectively developing and commercialising neuromodulation devices and includes executives and founders of Neuralink, Paradromics & Blackrock as well as DARPA Scientists.

MOWOOT is a growth stage medical device company treating intestinal transit disorders with a novel, purely physical, non-drug, non-invasive solution.

By Rory McCann, Marketing Manager & Conference Producer, LSN

Panel discussions are a popular feature at RESI partnering events. They are valuable tools for entrepreneurs to gather insight from those who are further up the road they are walking and can illuminate what hurdles they may encounter on their own fundraising journey. As the team at Life Science Nation prepares panels for Digital RESI JPM, we want to take the opportunity to share a sample of panel discussions at the past event.

Do you or a colleague have their own experience to share at Digital RESI JPM? Let us know and check out our lineup for next month’s virtual event. Looking to connect with investors and learn from colleagues in your industry? Sign up today to save $200 on early-bird rates!

Clinical & Research Data

Tales from the Road (RESI)

Women in Age-Tech

Impact Investors

By Rory McCann, Marketing Manager & Conference Producer, LSN

As Digital RESI November closes today, the team at Life Science Nation is looking ahead to Digital RESI JPM, January 11-13, 2022. In addition to RESI’s powerful partnering system, the virtual panels are a highlight for investors and fundraising entrepreneurs alike. RESI panels feature industry innovators and subject matter experts to discuss navigating the early-stage ecosystem within life science and healthcare, tackling topics relevant to fundraising and company-building.

Is there a topic you’d like to see at Digital RESI JPM? Would you recommend a particular industry expert or prolific investor to speak to fundraising in this space? We want to hear from you and highlight the issues and stories that are most meaningful to the RESI community. Send your suggestions to RESI@lifesciencenation.com and sign up for Digital RESI JPM by Friday, November 28 to save $300!

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Digital Redefining Early Stage Investment (RESI) returns to JP Morgan in its successful virtual format January 11-13, 2022! JPM Week is the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.

Digital RESI levels the playing field by offering quality content and compelling programs, like the Innovator’s Pitch Challenge, and match-based partnering fraction of the cost of the other partnering conferences.

	DIGITAL RESI @JPM	OTHER PARTNERING EVENTS (Virtual)
		@JPM	SPRING
Registration	$895	$1,795	€1,995
Registration + Pitch Fee	$1,695	$5,745	€2,240

*Prices as of today

The team at Life Science Nation understands the financial, logistical, and other non-tangible barriers to entry when it comes to early-stage fundraising. This is why Digital RESI is affordable, accessible, and designed to connect partnerships that are based on product fit and stage of development. To ensure founders are set up for optimal success, we also feature several complimentary fundraising bootcamps available to the public to introduce founders to our system, as well as provide resources and proven strategies to help them get started on the right foot!

Get to know your business development representative to learn what Digital RESI has to offer you on your unique fundraising journey and sign up for Digital RESI JPM, January 11-13 by November 28 to save $300 on super early bird rates.

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast  (USA)
Greg Mannix Vice President International Business Development Book a Meeting	Candice He Vice President of Business Development, Global Investment Strategist Book a Meeting	Antoinette Lowre Manager of Business Development Book a Meeting	Alexander Vassallo Manager of Business Development Book a Meeting